Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Inventory (2024 - 2025)

Madrigal Pharmaceuticals (MDGL) has disclosed Inventory for 2 consecutive years, with $74.8 million as the latest value for Q4 2025.

  • Quarterly Inventory rose 119.68% to $74.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $74.8 million through Dec 2025, up 119.68% year-over-year, with the annual reading at $74.8 million for FY2025, 119.68% up from the prior year.
  • Inventory for Q4 2025 was $74.8 million at Madrigal Pharmaceuticals, up from $69.3 million in the prior quarter.
  • The five-year high for Inventory was $74.8 million in Q4 2025, with the low at $854000.0 in Q1 2024.